Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
Search or
𝛼
SK
SIGN UP
SIGN IN
ENTITY
Balkrishna Industries (BIL IN)
Watchlist
66
Analysis
Consumer Discretionary
•
India
Balkrishna Industries Ltd. manufactures automobile tires and tubes. The Company also manufactures different varieties of paper & paper boards and processes synthetic textiles.
more
Watchlist
All
Insights
Primers
New
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Thematic (Sector/Industry)
•
04 Nov 2025 08:37
•
Broker
HSIE Results Daily: Maruti Suzuki, Bank of Baroda, Union Bank of India, Phoenix Mills...
Maruti Suzuki: Maruti Suzuki’s (MSIL) Q2FY26 EBITDA margin at 10.5% was in line with Bloomberg consensus estimate of 10.6%, but above our estimate...
HDFC Securities
Follow
146 Views
Share
bullish
•
Thematic (Sector/Industry)
•
10 Oct 2025 07:25
•
Broker
Autos (Q2FY26 Results Preview): Indian market well-poised amid global softness
While domestic focussed auto companies should get a fillip post the GST rate rationalization, leading to revival of growth rates, we will only see...
HDFC Securities
Follow
319 Views
Share
bullish
•
Thematic (Sector/Industry)
•
06 Sep 2025 03:39
•
Broker
Autos: GST Rate Cuts to Revive the Entry-Level Segment
Demand for entry-level cars and two wheelers has remained subdued post FY19 as emission norms, safety norms and general inflation have led to an...
HDFC Securities
Follow
357 Views
Share
bullish
•
Thematic (Sector/Industry)
•
31 Jul 2025 02:28
•
Broker
HSIE Results Daily: Torrent Pharma, Lodha, IndusInd Bank, Balkrishna Industries...
The company expects: (1) India to outperform IPM growth, driven by price increases, steady volumes, and new launches in focused therapies
HDFC Securities
Follow
240 Views
Share
bullish
•
Thematic (Sector/Industry)
•
30 Jul 2025 19:49
•
Broker
HSIE Results Daily: Torrent Pharma, Lodha, IndusInd Bank, Balkrishna Industries
The company expects: (1) India to outperform IPM growth, driven by price increases, steady volumes, and new launches in focused therapies
HDFC Securities
Follow
178 Views
Share
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.59.7
x